-
The use of large language models to enhance cancer clinical trial educational materials
Authors:
Mingye Gao,
Aman Varshney,
Shan Chen,
Vikram Goddla,
Jack Gallifant,
Patrick Doyle,
Claire Novack,
Maeve Dillon-Martin,
Teresia Perkins,
Xinrong Correia,
Erik Duhaime,
Howard Isenstein,
Elad Sharon,
Lisa Soleymani Lehmann,
David Kozono,
Brian Anthony,
Dmitriy Dligach,
Danielle S. Bitterman
Abstract:
Cancer clinical trials often face challenges in recruitment and engagement due to a lack of participant-facing informational and educational resources. This study investigated the potential of Large Language Models (LLMs), specifically GPT4, in generating patient-friendly educational content from clinical trial informed consent forms. Using data from ClinicalTrials.gov, we employed zero-shot learn…
▽ More
Cancer clinical trials often face challenges in recruitment and engagement due to a lack of participant-facing informational and educational resources. This study investigated the potential of Large Language Models (LLMs), specifically GPT4, in generating patient-friendly educational content from clinical trial informed consent forms. Using data from ClinicalTrials.gov, we employed zero-shot learning for creating trial summaries and one-shot learning for developing multiple-choice questions, evaluating their effectiveness through patient surveys and crowdsourced annotation. Results showed that GPT4-generated summaries were both readable and comprehensive, and may improve patients' understanding and interest in clinical trials. The multiple-choice questions demonstrated high accuracy and agreement with crowdsourced annotators. For both resource types, hallucinations were identified that require ongoing human oversight. The findings demonstrate the potential of LLMs "out-of-the-box" to support the generation of clinical trial education materials with minimal trial-specific engineering, but implementation with a human-in-the-loop is still needed to avoid misinformation risks.
△ Less
Submitted 3 December, 2024; v1 submitted 2 December, 2024;
originally announced December 2024.
-
Optimal Policy Sparsification and Low Rank Decomposition for Deep Reinforcement Learning
Authors:
Vikram Goddla
Abstract:
Deep reinforcement learning(DRL) has shown significant promise in a wide range of applications including computer games and robotics. Yet, training DRL policies consume extraordinary computing resources resulting in dense policies which are prone to overfitting. Moreover, inference with dense DRL policies limit their practical applications, especially in edge computing. Techniques such as pruning…
▽ More
Deep reinforcement learning(DRL) has shown significant promise in a wide range of applications including computer games and robotics. Yet, training DRL policies consume extraordinary computing resources resulting in dense policies which are prone to overfitting. Moreover, inference with dense DRL policies limit their practical applications, especially in edge computing. Techniques such as pruning and singular value decomposition have been used with deep learning models to achieve sparsification and model compression to limit overfitting and reduce memory consumption. However, these techniques resulted in sub-optimal performance with notable decay in rewards. $L_1$ and $L_2$ regularization techniques have been proposed for neural network sparsification and sparse auto-encoder development, but their implementation in DRL environments has not been apparent. We propose a novel $L_0$-norm-regularization technique using an optimal sparsity map to sparsify DRL policies and promote their decomposition to a lower rank without decay in rewards. We evaluated our $L_0$-norm-regularization technique across five different environments (Cartpole-v1, Acrobat-v1, LunarLander-v2, SuperMarioBros-7.1.v0 and Surgical Robot Learning) using several on-policy and off-policy algorithms. We demonstrated that the $L_0$-norm-regularized DRL policy in the SuperMarioBros environment achieved 93% sparsity and gained 70% compression when subjected to low-rank decomposition, while significantly outperforming the dense policy. Additionally, the $L_0$-norm-regularized DRL policy in the Surgical Robot Learning environment achieved a 36% sparsification and gained 46% compression when decomposed to a lower rank, while being performant. The results suggest that our custom $L_0$-norm-regularization technique for sparsification of DRL policies is a promising avenue to reduce computational resources and limit overfitting.
△ Less
Submitted 10 March, 2024;
originally announced March 2024.
-
Artificial Intelligence Solution for Effective Treatment Planning for Glioblastoma Patients
Authors:
Vikram Goddla
Abstract:
Glioblastomas are the most common malignant brain tumors in adults. Approximately 200000 people die each year from Glioblastoma in the world. Glioblastoma patients have a median survival of 12 months with optimal therapy and about 4 months without treatment. Glioblastomas appear as heterogeneous necrotic masses with irregular peripheral enhancement, surrounded by vasogenic edema. The current stand…
▽ More
Glioblastomas are the most common malignant brain tumors in adults. Approximately 200000 people die each year from Glioblastoma in the world. Glioblastoma patients have a median survival of 12 months with optimal therapy and about 4 months without treatment. Glioblastomas appear as heterogeneous necrotic masses with irregular peripheral enhancement, surrounded by vasogenic edema. The current standard of care includes surgical resection, radiotherapy and chemotherapy, which require accurate segmentation of brain tumor subregions. For effective treatment planning, it is vital to identify the methylation status of the promoter of Methylguanine Methyltransferase (MGMT), a positive prognostic factor for chemotherapy. However, current methods for brain tumor segmentation are tedious, subjective and not scalable, and current techniques to determine the methylation status of MGMT promoter involve surgically invasive procedures, which are expensive and time consuming. Hence there is a pressing need to develop automated tools to segment brain tumors and non-invasive methods to predict methylation status of MGMT promoter, to facilitate better treatment planning and improve survival rate. I created an integrated diagnostics solution powered by Artificial Intelligence to automatically segment brain tumor subregions and predict MGMT promoter methylation status, using brain MRI scans. My AI solution is proven on large datasets with performance exceeding current standards and field tested with data from teaching files of local neuroradiologists. With my solution, physicians can submit brain MRI images, and get segmentation and methylation predictions in minutes, and guide brain tumor patients with effective treatment planning and ultimately improve survival time.
△ Less
Submitted 9 March, 2022;
originally announced March 2022.
